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Abstract For all sensory organs, the establishment of spatial
and temporal cortical resolution is assumed to be initiated by
the first sensory experience and a BDNF-dependent increase in
intracortical inhibition. To address the potential of cortical BDNF
for sound processing, we used mice with a conditional deletion
of BDNF in which Cre expression was under the control of the
Pax2 or TrkC promoter. BDNF deletion profiles between these
mice differ in the organ of Corti (BDNFPax2-KO) versus the
auditory cortex and hippocampus (BDNFTrkC-KO). We demon-
strate that BDNFPax2-KO but not BDNFTrkC-KO mice exhibit
reduced sound-evoked suprathreshold ABR waves at the level
of the auditory nerve (wave I) and inferior colliculus (IC) (wave
IV), indicating that BDNF in lower brain regions but not
in the auditory cortex improves sound sensitivity during
hearing onset. Extracellular recording of IC neurons of
BDNFPax2 mutant mice revealed that the reduced sensi-
tivity of auditory fibers in these mice went hand in hand
with elevated thresholds, reduced dynamic range,
prolonged latency, and increased inhibitory strength in
IC neurons. Reduced parvalbumin-positive contacts were
found in the ascending auditory circuit, including the
auditory cortex and hippocampus of BDNFPax2-KO,
but not of BDNFTrkC-KO mice. Also, BDNFPax2-WT
but not BDNFPax2-KO mice did lose basal inhibitory
strength in IC neurons after acoustic trauma. These find-
ings suggest that BDNF in the lower parts of the audi-
tory system drives auditory fidelity along the entire as-
cending pathway up to the cortex by increasing inhibi-
tory strength in behaviorally relevant frequency regions.
Fidelity and inhibitory strength can be lost following
auditory nerve injury leading to diminished sensory out-
come and increased central noise.
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Abbreviations
ABR Auditory brainstem response
AC Auditory cortex
Arc Activity-regulated cytoskeletal protein
AT Acoustic trauma
BBN Broadband noise
BDNF Brain-derived nerve growth factor
CF Characteristic frequency
CN Cochlear nucleus
DCN Dorsal cochlear nucleus
DPOAE Distortion product of the otoacoustic emission
IC Inferior colliculus
IHC Inner hair cell
KO Knockout
mFSL Minimum first-spike latency
OHC Outer hair cells
PV Parvalbumin
RIF Rate-intensity function
ROSA26R ROSA26 reporter mouse
SGN Spiral ganglion neuron
SPL Sound pressure level




Brain-derived neurotrophic factor (BDNF) was initially iden-
tified as a survival factor for peripheral neurons (reviewed in
[1, 2]). Increasing evidence is now emerging that BDNF acts
locally as a factor that governs dendritogenesis and the spine
phenotype [3–6] at certain stages of maturation [7]. Upon
sensory experience in the auditory [8, 9], visual [10], somato-
sensory [11], and olfactory system [12], the dendritic com-
plexity of parvalbumin (PV)-immunoreactive interneurons is
particularly enhanced in response to increases in local cortical
BDNF [4, 8, 11]. This process is assumed to enhance sensory
resolution and acuity, and requires an adequate and timely
sensory input [13–15]. The selective role of cortical BDNF
for improvement of sensory resolution was questioned in the
retina where BDNF was proposed as a mediator of early en-
vironmental enrichment effects on visual acuity [16]. Accord-
ingly, blocking retinal BDNF by means of antisense oligonu-
cleotides prior to eye openingwas shown to prevent the effects
on dendritic segregation of retinal ganglion cells [17] and
development of retinal acuity [16] upon exposure to environ-
mental enrichment. As constitutive BDNF knockout (KO)
mice [18, 19] die too prematurely to assess the role of BDNF
in the mature sensory organs, the role of peripheral versus
central BDNF for sensory resolution and acuity is still ob-
scure. Until now, it also remains unclear if and how these
crucial effects of BDNF during the development of normal
sensory function are linked to the complex changes of BDNF
activity in mature systems, which have been described as ei-
ther adaptive responses to injury [20] or nonadaptive re-
sponses in various brain disorders [21].
In rodent auditory systems, BDNF is downregulated in hair
cells of the cochlea from birth onwards but remains expressed
in the inner border and phalangeal cells that ensheath inner
hair cells (IHCs) [22] and is upregulated with hearing onset in
spiral ganglion neurons (SGNs) at the level of higher frequen-
cy cochlear turns (for a review, see [15]). While loss of BDNF
in phalangeal cells does not affect hearing [23], the combined
deletion of BDNF in the cochlea, the dorsal cochlear nucleus
(DCN), and the inferior colliculus (IC) in BDNFPax2-KOmice
[24, 25] leads to reduced exocytosis of otherwise mature IHC
synapses and to slightly diminished sound-induced auditory
brainstem responses [25]. This finding suggested an unexpect-
ed role of BDNF in the lower parts of the auditory pathway for
hearing sensitivity upon sensory experience. To obtain more
insight into such a role of BDNF on basic sound processing,
we compared sound sensitivity and noise vulnerability of
BDNFPax2-KO mice with that of mice in which BDNF is
deleted more widespread throughout the auditory system in-
cluding the auditory cortex using a mouse line in which Cre is
driven by the TrkC promoter [26]. Strikingly, reduced sound
sensitivity occurs only in BDNFPax2-KO mice but not in
BDNFTrkC-KO mice. This differential response is observed
although both strains exhibit a similar BDNF deletion profile
in the SGNs of the cochlea and in the IC, the midbrain inte-
gration center of the ascending auditory pathway [27, 28]
[present study]. Results from recordings of extracellular
sound-evoked responses from IC neurons in BDNFPax2
wild-type (WT) and BDNFPax2-KO mice and measurements
of the density of inhibitory marker proteins along the auditory
pathway and hippocampus suggest that BDNF in the lower
parts of the auditory CNS or within the cochlea triggers basal
PV inhibitory circuits to increase auditory fidelity upon sen-
sory experience. However, this early improvement of sensitiv-
ity is accompanied by the risk to lose sensitivity and generate
elevated noise levels when the BDNF-modified driving force




BDNFPax2-KO mice were obtained by mating Pax2-Cre [24]
with BDNFlox/lox mice [29]. BDNFTrkC-KO mice were gener-
ated by mating TrkC-Cre [26] with BDNFlox/lox mice.
BDNFPax2-KO mice had a deletion of BDNF in the cochlea,
DCN, and IC [25]. In BDNFTrkC-KO mice, BDNF was con-
ditionally inactivated in neurons. TrkC-Cre mice and Pax2-
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Cre mice were crossed with ROSA26 reporter (ROSA26R)
mice as described [25]. For detection of β-galactosidase ac-
tivity in the Pax2-Cre-ROSA26R or TrkC-Cre-ROSA26R
mouse line, adult mice were used. β-Galactosidase activity
was analyzed through X-gal staining and immunohistochem-
istry with anti-β-galactosidase antibody as described below.
Deletion of the BDNF gene in distinct brain areas of
BDNFPax2-KO and BDNFTrkC-KO mice was verified by
Northern and Western blots. Control and knockout mice of
either sex were used for the experiments.
The care and use of animals was approved by either the
University of Tübingen, Veterinary Care Unit and the Animal
Care and Ethics Committee of the regional board of the Fed-
eral State Government of Baden-Württemberg, Germany, or
by the Ethics Committee of the Institute of ExperimentalMed-
icine, Academy of Sciences of the Czech Republic, and
followed the guidelines of the EU Directive 2010/63/EU for
animal experiments.
Tissue Preparation, X-gal Staining,
Immunohistochemistry, and Ribbon Counts
Cochlear and brain tissues were isolated and dissected as pre-
viously described [30]. Briefly, cochleae and brains were fixed
in 100 mM phosphate-buffered saline (PBS) containing 2 %
paraformaldehyde and 125mM sucrose, pH 7.4, for 2 and 48 h,
respectively. Cochleae were decalcified in Rapid Bone
Decalcifier (Eurobio, Les Ulis Cedex, France) followed by an
overnight incubation in 25 % sucrose in Hanks’ buffered saline
(HBS). Cochleae were embedded in O.C.T. compound (Miles
Laboratories, Elkhart, IN, USA). Tissue samples were
cryosectioned at 10 μm thickness for immunohistochemistry,
mounted on Super-Frost*/plus microscope slides, and stored at
−20 °C [31]. Brains were embedded after fixation in 4 % aga-
rose, cut at 60 μm thickness with a Vibratome (Leica VT
1000S, Wetzlar, Germany), and stored in PBS at 4 °C. Brain
regions were identified in accordance with the mouse atlas of
Franklin and Paxinos [32]. Serial sections derived from coronal
brain slices between 1.8 and 2.3 mm posterior to bregma were
analyzed. For cochlear whole-mount preparations, the temporal
bone was dissected on ice and immediately fixed for 2 h using
2% paraformaldehyde in 100mMPBS by infusion through the
round and oval window. Cochlear turns were dissected and
transferred to slides and attached to the surface using Cell-Tak
(BD Bioscience, Heidelberg, Germany).
For X-gal staining, brain slices and isolated cochleae, slit
from the apex to base, were incubated with the β-galactosi-
dase staining solution containing 0.5 mg/ml X-gal (Sigma),
5 mM K3[Fe(CN)6], and 5 mM K4[Fe(CN)6] in PBS
complemented with 20 mM MgCl2, 0.01 % sodium
deoxycholate, and 0.02 % Nonidet-P40 overnight at 37 °C.
After incubation with β-galactosidase staining solution,
whole-mount preparations of the cochleae were performed.
In case of a successful deletion of the floxed ROSA26R locus,
the presence of β-galactosidase protein is visualized with the
enzyme’s substrate (X-gal), resulting in a blue precipitate only
in cells expressing Cre recombinase.
Immunohistochemistry was performed as described before
[33, 34]. Briefly, after washing and permeabilization, tissue
slices were incubated overnight with primary antibody at 4 °C.
For double labeling studies, specimens were simultaneously
incubated with both antibodies. Primary antibodies were de-
tected with Cy3-conjugated (Jackson ImmunoResearch) and
AlexaFluor 488-conjugated secondary antibodies (Life Tech-
nologies GmbH, Darmstadt, Germany). Slices were mounted
with Vectashield mounting medium containing DAPI (Vector
laboratories, Burlingame, CA, USA). Sections and whole-
mount preparations were viewed using an Olympus BX61
microscope equipped with epifluorescence illumination.
For ribbon counting, image acquisition and CtBP2/
RIBEYE-immunopositive spot counting were carried out as
previously described [33]. Briefly, cryosectioned cochleae
were imaged over a distance of 8 μm covering the entire
IHC nucleus and beyond in an image-stack along the z-axis
(z-stack). One z-stack consisted of about 16 layers with a z-
increment of 0.49 μm; for each layer, one image per fluoro-
chrome was acquired. To assess spatial protein distribution, z-
stacks were three-dimensionally deconvoluted using the
cellSens constrained iterative module with the Advanced
Maximum Likelihood Estimation (ADMLE) algorithm (OSIS
GmbH), Voxel Viewer, and Slice Viewer (cellSens, OSIS
GmbH).
Antibodies The following antibodies were used: mouse
anti-β-galactosidase (Promega, Mannheim, Germany), mouse
anti-parvalbumin, rabbit anti-SK2 (Sigma-Aldrich, Munich,
Germany), rabbit anti-GFAP (Dako, Glostrup, Denmark), rab-
bit anti-parvalbumin, mouse anti-GAD67 (Merck Millipore,
Darmstadt, Germany), rabbit anti-Arc, rabbit anti-VGLUT2,
rabbit anti-MAP2 [35] (Synaptic Systems, Göttingen, Germa-
ny), rabbit anti-Iba1 (Wako Chemicals GmbH, Neuss, Germa-
ny), rabbit anti-BDNF (Santa Cruz Biotechnology, Heidel-
berg, Germany), rabbit anti-BK (Alomone Labs, Jerusalem,
Israel), rabbit anti-CtBP2/RIBEYE (Cell Applications, San
Diego, CA, USA), and rabbit anti-KCNQ4 [36].
Image Analysis The acquired images were analyzed using the
free software ImageJ (NIH, Bethesda, MD, USA) to evaluate
the expression of parvalbumin and GAD67. In every picture,
the background was reduced with the rolling ball algorithm,
and therefore, the red, green, and blue channels have been
separated. In the green channel (parvalbumin or GAD67), a
threshold (with ImageJ standard parameters) has been applied
and therefore the ImageJ built-in plugin, Analyze Particles,
has been used to count the numbers of parvalbumin or
GAD67 puncta.
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Northern Blots
Riboprobes were designed as described in [30]. Messenger
RNA (mRNA) isolation was performed using the Oligotex
mRNADirect Mini Kit (Qiagen, Germany). mRNAwas load-
ed onto a denaturing 0.8 % agarose formaldehyde gel and
transferred onto a nylon membrane (Roche, Germany). The
membrane was blocked and hybridized overnight at 65 °C
with riboprobes for BDNF, Arg3.1, and cyclophilin. The
membrane was incubated with anti-Dig-AP (Roche; 1:20,
000). mRNA was detected with CDP-Star ready to use
(Roche) and exposed to X-ray films.
Western Blots
Proteins were extracted using the NucleoSpin RNA/protein kit
(Macherey-Nagel, Germany) following the manufacturer’s in-
structions. SDS-PAGE and Western blotting were carried out
using the “XCell II SureLock™ Mini-Cell and XCell II Blot
Module” (Invitrogen, Germany) as previously described [37].
The blotted proteins were incubated with either rabbit polyclon-
al or mouse monoclonal antibodies for BDNF (Santa Cruz Bio-
technology, Heidelberg, Germany), activity-regulated cytoskel-
etal protein (Arc) (Synaptic Systems, Göttingen, Germany),
parvalbumin (Merck Millipore, Darmstadt, Germany),
GAD67 (Merck Millipore, Darmstadt, Germany), or GAPDH
(Abcam, Cambridge, UK).
Noise Exposure
For acoustic trauma (AT), animals were anesthetized
(75 mg/kg ketamine hydrochloride, Ketavet, Pharmacia,
Pfizer, Karlsruhe, Germany; 5 mg/kg xylazine hydrochloride,
Rompun 2 %, Bayer Leverkusen, Germany; in injection water
to give an application volume of 5 ml/kg body weight) and
exposed to intense pure tone noise (10 kHz, 116 dB sound
pressure level (SPL) for 40 min) in a reverberating chamber,
binaurally in an open field [25]. Control sham-exposed ani-
mals underwent the same procedure but with no traumatic
sound presented (i.e., the speaker remained turned off).
Hearing Function Evaluation
Hearing thresholds were evaluated from auditory brainstem
responses (ABRs). The state of outer hair cells (OHCs) in
the organ of Corti was studied by recording otoacoustic emis-
sions. The ABR to click and pure tone stimuli and the cubic
2× f1− f2 distortion product of the otoacoustic emission
(DPOAE) for f2=1.24×f1 and L2=L1−10 dB were recorded
in mice aged 6–9 weeks. All physiological recordings were
performed under anesthesia (for details, see above) in a sound-
proof chamber (IAC, Niederkrüchten, Germany) as previous-
ly described [38].
Auditory Brainstem Responses ABRs, evoked by short-
duration sound stimuli, represent the summed activity of neu-
rons in distinct anatomical structures or nuclei along the as-
cending auditory pathway [39] and are measured by averaging
the evoked electrical response recorded via subcutaneous elec-
trodes. Briefly, ABRs were evoked by click (100 μs) or pure
tone stimuli (3 ms duration, 1 ms rise/fall times, frequencies
2–45.3 kHz) of gradually increasing sound pressure in 5 dB
steps of intensity. The response threshold was determined at
each frequency as the minimal sound pressure evoking a no-
ticeable potential peak in the expected time window of the
recorded signal. For details, see [38].
Distortion Product Otoacoustic Emissions We assessed
OHC function by the growth function and the maximum re-
sponse in the distortion product audiogram of the cubic
DPOAE as described [34]. Frequency pairs of tones were
between f2=4 kHz and f2=32 kHz.
ABRWave Form Analysis
ABR waveforms were analyzed for consecutive amplitude
deflections (waves), with each wave consisting of a starting
negative (n) peak and the following positive (p) peak. Peak
amplitudes of ABR waves I and IV were extracted in the
present study and defined as wave I: In−Ip (0.9–2 ms); wave
IV: IVn−IVp (3.4–5.9 ms). A customized programwas used to
extract ABR peaks based on these definitions. ABR peak-to-
peak (wave amplitude) growth functions were constructed for
individual ears based on the extracted peaks for increasing
stimulus levels. All ABR wave amplitude growth functions
were calculated for increasing stimulus levels with reference
to the ABR thresholds (from −20 to a maximum of 75 dB
above threshold before noise exposure and from −20 to a
maximum of 55 dB above threshold after noise exposure).
For illustrative purposes, ABR wave amplitude growth func-
tions were first linearly interpolated to the resolution of 1 data
point/dB and then smoothed by a moving zero-phase Gauss-
ian filter with a window length of 9 data points (9 dB). The
ABR waveforms shown in the inset of the figures were
smoothed by a moving zero-phase Gaussian filter with a win-
dow length of 5 data points (0.5 ms).
Extracellular Recording of the Neuronal Activity in the IC
Four groups of animals were tested: control, wild-type (WTc,
n=4), and knockout (KOc, n=4) mice and mice with auditory
trauma, WTat (n=5) and KOat (n=5). Mice with auditory
trauma were exposed to noise at the age of 9–10 weeks and
extracellular recordings were performed at 13–20 weeks. The
surgery and extracellular recording in the IC were performed
inmice anesthetizedwith 35mg/kg ketamine (Narkamon 5%;
Spofa, Prague, Czech Republic) and 6 mg/kg xylazine
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(Sedazine 2 %; Fort Dodge, Animal Health, Fort Dodge, Io-
wa) in saline via intraperitoneal injection. Body temperature
was maintained with a DC-powered electric temperature-
regulated pad. Recordings were carried out in a soundproof
anechoic room.
Surgical and Recording Procedures For access to the IC, an
incision was made through the skin of the skull and underly-
ing muscles were retracted to expose the dorsal cranium. A
holder was glued to the skull. Small holes were drilled over
both IC of the mouse; the animal was transported to the sound-
proof anechoic room and placed on a heating pad, which
maintained a 37–38 °C body temperature. Neuronal activity
in the IC was recorded using a 16-channel, single shank probe
(NeuroNexus Technologies) with 100 μm between the elec-
trode spots or single parylene-coated tungsten electrode (Bi-
onic Technologies Inc). The signal obtained from the elec-
trode was amplified 10,000 times, band-pass filtered over
the range of 300 Hz to 10 kHz, and processed by a TDT
System III (Tucker Davis Technologies, Alachua, FL, USA)
using an RX5-2 Pentusa Base Station. The recorded data was
processed and analyzed with a custom software based on
MATLAB.
Frequency-Intensity Mapping Using frequency-intensity
mapping as described in [40], the tuning properties of individ-
ual IC neurons were evaluated. To determine the excitatory
response area, pure tone bursts (100 ms in duration, 5 ms
rise/fall times) with variable frequency (1/8 octave step) and
intensity (5 dB step) were presented in random order.
A two-dimensional matrix was thereby obtained, with ele-
ments corresponding to the response magnitudes in the re-
spective frequency-intensity points. The discrete point matrix
was then converted to a smooth function of two variables,
frequency and intensity, a process involving cubic smoothing
spline interpolation. This averaging method allowed us to
overcome the limited resolution of the frequency-intensity
map. The resulting smooth function thereafter served as a
basis for the extraction of all the parameters of interest: (i)
the excitatory response threshold, the lowest stimulus intensi-
ty that excited the neuron, measured in dB SPL; (ii) the char-
acteristic frequency (CF), the frequency with the minimal re-
sponse threshold, measured in kHz; and (iii) the bandwidth of
the excitatory area 10 dB above the excitatory threshold, mea-
sured by quality factor Q10. Quality factor Q10 is a common
measure of frequency selectivity that is reciprocally related to
the excitatory area bandwidth (the higher the Q10, the sharper
the response), defined as Q10=CF/bandwidth.
Two-Tone Stimulation To detect inhibitory areas, a two-tone
stimulation was employed [40]. Two-tone inhibition in the IC
consists of two components: intrinsic inhibition and
suppression from lower auditory centers. Local inhibition is
typically characterized by the effects of off-CF tones on spon-
taneous activity. Also the two-tone stimulation paradigm is
commonly used to evaluate the local inhibition on the level
of the cochlear nucleus (CN) [41–43], the IC [44, 45], and the
auditory cortex (AC) [46]. Using the two-tone stimulation, the
contribution of cochlear suppression cannot be excluded in the
current study. However, we conclude that central inhibition on
the level of the IC mainly contributes to the neural inhibition,
since the shapes of the inhibitory areas in representative neu-
rons stimulated with two-tone stimulation corresponded well
with those obtained by inhibition of spontaneous activity. Pure
tone at the neuron’s CF fixed 10 dB above the threshold at CF
and pure tone bursts of variable frequency and intensity, anal-
ogous to those used for the excitatory area mapping, were
simultaneously presented. Similar to frequency-intensity map-
ping, a two-dimensional matrix was obtained. Spike rates of
responses in noninhibited areas (outside the excitatory area),
inhibited areas, and excited areas (20 dB above threshold)
were determined. Inhibitory strength was calculated as the
ratio of spike numbers per stimulus in inhibited areas to those
in noninhibitory areas. Low- and high-frequency inhibition
bands were analyzed separately. Neurons displaying inhibi-
tion with a strength of 20 % and higher were considered to
be neurons displaying inhibition, and their numbers were
compared between groups. In addition to inhibitory strength,
the ratio of response magnitude in excitatory to noninhibitory
areas was evaluated.
Intensity Coding in the ICNeuronal responses to broadband
noise (BBN) bursts of variable intensity (from 0 to 90 dB SPL,
10 dB steps, 50 repetitions) were used to construct the rate-
intensity function (RIF) from which response threshold, max-
imal response magnitude, dynamic range, and relative initial
slope of the RIF were determined [47]. From the RIF, further
response parameters such as spontaneous firing rate and first-
spike latency were assessed. Spontaneous firing rate of each
neuron was determined from poststimulus time histograms to
BBN stimulation from 200–300 ms after presentation of the
stimulus 10 dB above the threshold. Minimum first-spike la-
tency (mFSL) was evaluated from the poststimulus time his-
tograms to BBN stimuli at 80 dB SPL, as the amount of time
between the onset of sound presentation and the appearance of
first spikes of neuronal responses.
Statistical Analysis
Data are presented either as the mean±standard deviation
(SD) or standard error of the mean (SEM) for values with
normal distributions or the median (Mdn) for values with
nonnormal distributions. For statistical analysis, the GraphPad
Prism software was used. To assess differences in mean or
median values between groups, two-sided Student’s t tests,
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one-way or two-way ANOVA with Bonferroni’s multiple
comparison test, Kruskal-Wallis tests with Dunn’s multiple
comparison test, or chi-square tests were employed.
Results
Differential Deletion of BDNF in the Cochlea and Brain
in Pax2-Cre Versus TrkC-CreMouse Lines
To define the source of BDNF that is responsible for the ab-
sence of normal hearing thresholds of BDNFPax2-KO animals
[25], we compared the auditory phenotype of BDNF-Pax2-
Cre transgenic mice with that of BDNF-TrkC-Cre mice, in
which the Cre gene is controlled by the TrkC promoter [26].
A detailed comparative analysis of BDNF deletion patterns in
the ascending auditory pathway was performed for both Cre
mouse lines, using X-gal staining and anti-β-galactosidase (β-
gal) immunolabeling (Fig. 1). X-gal staining confirmed in-
tense labeling of hair cells and SGNs for Pax2-Cre-ROSA26R
mice (Fig. 1a, upper panel), whereas for TrkC-Cre-ROSA26R
mice, X-gal staining was observed mainly in SGNs but not in
hair cells (Fig. 1b, upper panel). A similar result was observed
when β-gal immunolabeling was used (Fig. 1a, b, lower
panels). Negative controls showed no staining (Fig. 1a, b,
inset).
At the level of the CN, β-gal was detected exclusively in
the DCN in the presence of the Pax2 promoter [25], whereas
with the TrkC promoter, DCN and ventral cochlear nucleus
(VCN) neurons were stained (not shown). In both Pax2-Cre-
ROSA26R and TrkC-Cre-ROSA26R mice, an intense and
widespread staining for β-gal was observed at the level of
the IC (Fig. 1c, d). In contrast, in the AC and hippocampus
(Fig. 1c, d), TrkC-Cre-ROSA26R but not Pax2-Cre-
ROSA26R mice exhibited β-gal staining (Fig. 1c, d). A sim-
ilar deletion pattern of BDNF in both BDNFPax2-KO and
BDNFTrkC-KO mice was confirmed by the almost complete
loss of the 4-kB and 1.8-kB BDNF transcripts and the absence
of the 14-kDa BDNF polypeptide using Northern andWestern
blots, respectively (Fig. 1e, f, IC) [25]. In contrast, only in
BDNFTrkC-KO but not BDNFPax2-KO mice, BDNF mRNA
and protein were absent at the level of the AC (Fig. 1e, f) [25].
The overall deletion pattern is summarized in Fig. 1g, f. In the
IC, β-gal (Fig. 2a, d, green) and BDNF immunoreactivity
(Fig. 2c, f, red) were found in PV-immunopositive and PV-
immunonegative neurons in both BDNFPax2-WT and
BDNFTrkC-WT mice. The specificity of BDNF staining in
these neurons was confirmed using BDNFPax2-KO and
BDNFTrkC-KO animals (Fig. 2c, f). Colabeling with the neu-
ronal microtubule-associated protein MAP2 and the gluta-
matergic marker protein VGLUT2 indicated that PV-
immunoreactive neurons in the IC may correspond to projec-
tion neurons (not shown). On the other hand, colabeling of β-
gal with either the oligodendrocyte marker GFAP or the mi-
croglia marker Iba1 [48] in Pax2-Cre-ROSA26R and TrkC-
Cre-ROSA26R mice (Fig. 2b, e) confirmed that β-gal was
preferentially localized in the neurons of the IC.
Therefore, BDNFPax2-KO and BDNFTrkC-KOmice exhibit
comparable BDNF deletion profiles in the IC, DCN, and
SGNs (Fig. 1g, h, green dots) and were expected to develop
similar hearing defects.
Deletion of BDNF in BDNFPax2-KO but not
BDNFTrkC-KO Mice Constricts Sound-Induced ABR
Waves
We thus measured hearing function in both BDNF mutant
strains as described previously [25] and were surprised to ob-
serve significant differences. As shown in Fig. 3a (upper panel),
BDNFPax2-KO mice exhibited slightly increased hearing
thresholds (WTc, n=6/12 ears/mice, 18.6±3.92; KOc, n=6/12
ears/mice, 30.3±5.3; one-way ANOVA p<0.001; n.s. not sig-
nificant; ***p<0.001 Bonferroni’s multiple comparison test),
which have been linked with reduced exocytosis and ribbon
numbers in otherwise mature IHC synapses in high-frequency
cochlear turns [25]. After noise exposure, the loss of hearing
thresholds in BDNFPax2-KO animals is, however, significantly
less pronounced than in BDNFPax2-WT mice (Fig. 3a, upper
panel, WTat, n=8/16 ears/mice, 64.5±16.64; KOat, n=8/16
ears/mice, 41.9±16.71; one-way ANOVA p<0.001; n.s. not
significant; ***p<0.001Bonferroni’smultiple comparison test)
[25]. In contrast, BDNFTrkC-KO mice did not exhibit any dif-
ferences in hearing thresholds compared to age-matched
BDNFTrkC-WTmice, as assessed by click-evoked (Fig. 3a, low-
er panel, WTc, n=22/11 ears/mice, 19.6±6.38; KOc, n=20/10
ears/mice, 20.7±7.52; p=0.999) and frequency-dependent
(Fig. 3b, WTc, n=22/11 ears/mice; KOc, n=10/10 ears/mice;
p=0.684) hearing measurements before and after AT (Fig. 3a,
WTat, n=8/8 ears/mice, 40.7±19.54; KOat, n=7/7 ears/mice,
48.0±18.03; p=0.543 for click-evoked ABR, p=0.419 for
frequency-dependent ABR). Also, mean numbers of IHC rib-
bons in BDNFTrkC-KOmice before and after ATwere similar to
that in BDNFTrkC-WT mice (Fig. 3d). This indicates that the
BDNF deletion under the Pax2 but not the TrkC promoter
slightly reduced sound sensitivity.
Despite the differences in hearing thresholds, BDNFTrkC-KO
and BDNFPax2-KO mice did not differ in OHC function, based
on DPOAEs (Fig. 3c, n=20/10 ears/mice) [25]. Consistent with
BDNF acting at the level of the IHC-afferent nerve fiber,
suprathreshold amplitudes of spreading auditory nerve activity
(wave I) and midbrain activity (lateral lemniscus and IC, wave
IV) were significantly reduced before AT but less affected after
AT in BDNFPax2-KO compared to BDNFPax2-WT mice
(Fig. 3e, WTat, n=8; KOat, n=8). This effect was not observed
in BDNFTrkC-KO animals (Fig. 3f, wave I: p=0.885, wave IV:
p=0.814; WTc, n=17/9 ears/mice; KOc, n=15/8 ears/mice;
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Fig. 1 Differential BDNF deletion patterns under the Pax2 or the TrkC
promoter. a, bX-gal staining and β-gal immunolabeling of mice carrying
the Pax2-Cre (a) or the TrkC-Cre transgene (b) on a ROSA26R
background. a In the mature cochlea, β-galactosidase activity in Pax2-
Cre-ROSA26R mice was detected in inner (IHC) and outer hair cells
(OHC) of the organ of Corti (OC) and in spiral ganglion neurons
(SGN). b β-Galactosidase activity in TrkC-Cre-ROSA26R mice was
detected mainly in SGNs, but not in hair cells, as demonstrated by
immunohistochemistry. c Immunohistochemistry for β-gal in the
inferior colliculus (IC), auditory cortex (AC), and hippocampus of
Pax2-Cre-ROSA26R mice. In the IC, β-gal staining can be detected,
whereas no expression is observed in the AC and hippocampus. d
Immunohistochemistry for β-gal in the IC, AC, and hippocampus of
TrkC-Cre-ROSA26R mice. Clear β-gal staining is observed in the IC,
AC, and hippocampus. In Cre-negative mice, no β-gal staining is seen
(insets). Scale bars=a, b 10 μm; c, d 100 μm. e Northern and Western
blots from IC and AC tissues of wild-type (WT) and BDNFPax2 knockout
(KO) mice demonstrating a deletion of BDNF mRNA isoforms (1.8 and
4 kb) and BDNF protein (14 kDa) in the IC but not in the AC of
BDNFPax2-KO mice. f Northern and Western blots from IC and AC
tissues of WT and BDNFTrkC-KO mice demonstrating a deletion of
BDNF mRNA isoforms (1.8 and 4 kb) and protein (14 kDa) in the IC
and AC of BDNFTrkC-KOmice. For Northern blots, cyclophilin (CP) was
used as a reference (0.8 kb); for Western blots, GAPDH (40 kDa) was
used as a loading control. g, hDiagrams of the auditory pathway: the area
of BDNF deletion exclusively in either the BDNFPax2-KO or the
BDNFTrkC-KO is marked in dark red; the area of BDNF deletion in
both BDNF-KO mouse lines is marked in bright red. g BDNF deletion
in BDNFPax2-KO mice, h BDNF deletion in BDNFTrkC-KO mice
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control “c” vs. acoustic trauma “at”: WTc, n=8/4 ears/mice;
KOc, n=8/4 ears/mice; WTat, n=8/4 ears/mice; KOat, n=7/4
ears/mice). Likewise, the growth of suprathreshold ABR am-
plitudes to increasing sound intensities was affected in
BDNFPax2-KO but not in BDNFTrkC-KO mice (compare
Fig. 3g, h with i, j). Whereas ABR waves I and IVof trauma-
tized BDNFPax2-KO mice were significantly less elevated in
comparison to those of BDNFPax2-WT mice, no significant
variations in DPOAEs (p=0.056, n=8/4 ears/mice) were ob-
served after AT. Also the SPLs that generated significant differ-
ences in ABR wave I and IV 20 dB above thresholds in
BDNFPax2-WTandBDNFPax2-KO (Fig. 3g, h) were far beyond
the stimulus levels (15–30 dB SPL) where variations in the
DPOAE response between BDNFPax2-WT and BDNFPax2-
KO mice were apparent [25]. Therefore, in the range of the
stimulus levels in which the ABR functions were quantified,
no difference in DPOAE responses can be found between
BDNFPax2-WTand BDNFPax2-KO animals. This indicates that
the BDNF deletion under the Pax2 promoter may reduce sound
sensitivity independently of OHC functions.
To further strengthen the point that the threshold differ-
ences between BDNFPax2-WT and BDNFPax2-KO are not
caused by defects in OHC function, the phenotype of OHCs
and their efferent and afferent synapses were studied in more
detail. As exemplarily shown for midbasal turns, no obvious
differences of the morphology of pre- and postsynapses of
OHCs were observed between BDNFPax2-WT and
BDNFPax2-KO mice. This was judged on the basis of expres-
sion of OHC marker proteins such as the outward-rectifying
potassium channel KCNQ4 (Fig. 4a) or the Ca2+-binding pro-
tein parvalbumin (Fig. 4b). Also markers for pre- and post-
synaptic efferent contacts such as SK2 and BK (Fig. 4c, d)
[49, 50] and the numbers of CtBP2-stained OHC ribbons were
similar between BDNFPax2-WT and BDNFPax2-KO mice
(Fig. 4e, g), whereas IHC ribbons in the latter animals were
reduced (Fig. 4f, g).
These findings suggest that BDNF deletion under the Pax2
but not the TrkC promoter reduced evoked sound amplitudes
independently of OHC function. After AT, the weaker reduc-
tion of amplitudes in BDNFPax2-KO pointed to a sound sen-
sitivity that cannot be lost after AT, because it has never been
enhanced via a sensory experience by BDNF.
The similar deletion profiles of BDNF in BDNFPax2-KO and
BDNFTrkC-KO mice shown by immunohistochemistry and
Western and Northern blot analyses in the IC suggest that the
IC is unlikely to be the BDNF source responsible for the altered
sound sensitivity observed in BDNFPax2-KO mice. As BDNF
in the VCN or olivary complex is not deleted using the Pax2
promoter [25], the effects of BDNF acting from the superior
olivary complex are also unlikely to play a role. Finally, since
BDNF released from projection neurons is assumed to drive
interneuron stability and not vice versa [51], loss of BDNF in
PV-expressing inhibitory interneurons that are suggested to de-
rive from Pax2 precursors [52] is probably not involved in the
auditory phenotype of BDNFPax2-KO mice. Therefore, influ-
ences from intracortically expressed BDNF acting through de-
scending pathways are very unlikely to be the underlying cause
for the auditory phenotype in the BDNFPax2-KO animals, as in
these mice BDNF is not deleted in the AC (Fig. 1c). Thus,
BDNF in the lower parts of the auditory CNS or within the
cochlea has to be considered as the most likely source respon-
sible for altered sound sensitivity before and after AT in
BDNFPax2-KO mice.
Deletion of BDNF in BDNFPax2-KO Constricts CF
Thresholds and Dynamic Range in IC Neurons
To understand the physiology behind the reduced range of
suprathreshold ABR responses generated at the level of the IC
in BDNFPax2-KO mice (Fig. 3e, h), we analyzed the electro-
physiological response behavior of single IC neurons in 3–4-
month-old BDNFPax2-WTandBDNFPax2-KOmice, 3–4weeks
after sham or traumatizing acoustic exposure. The responses to
BBN and pure tones of a total of 1069 IC units were recorded,
comprising 264 units from WTc (n=4), 232 from KOc (n=4),
254 from WTat (n=5), and 404 from KOat (n=5).
Since ATwas produced by exposure to a 10-kHz pure tone,
the whole sample of units was divided into three main non-
overlapping frequency bands according to their CF: 4–9 kHz
(low), 10–15 kHz (middle), and 16–30 kHz (high). The
thresholds of IC neurons to BBN stimulation were significant-
ly higher in BDNFPax2-KO than in BDNFPax2-WT mice
(Fig. 5a, BDNFPax2-KOc, 38.62±9.6 dB SPL; BDNFPax2-
WTc, 24.78±10.76 dB SPL; ****p<0.0001). After AT, in
KO animals (∼20 dB), these thresholds were significantly less
pronounced than in WT mice (∼40 dB; Fig. 5a, b). Also,
response thresholds to tone stimulation at neuronal CF 10–
15 kHz and 16–30 kHz were significantly higher in
BDNFPax2-KO than in BDNFPax2-WT mice (Fig. 5b, middle
Fig. 2 Immunohistochemistry of the IC of Pax2-Cre-ROSA26R and
TrkC-Cre-ROSA26R mice and BDNFPax2 and BDNFTrkC WT and KO
mice. a, d Immunostaining with anti-β-galactosidase (β-gal, green) and
anti-parvalbumin (red) showing coexpression of β-galactosidase and
parvalbumin in IC sections from both Pax2- and TrkC-Cre-ROSA26R
mice. b, e Co-immunostaining with anti-β-galactosidase (β-gal, green)
and either the oligodendrocyte marker anti-GFAP (red, open arrow) or
the microglia marker anti-Iba1 (red, open arrow) in IC sections from both
Pax2- and TrkC-Cre-ROSA26R mice shows no coexpression of β-
galactosidase and GFAP or Iba1. Therefore, β-galactosidase is detected
in neuronal cells. c, f Immunohistochemistry of IC sections stained with
anti-BDNF (red) and anti-parvalbumin (green) antibodies, showing
BDNF immunoreactivity in PV-positive and PV-negative neurons in
BDNFPax2-WT (c, upper row) and BDNFTrkC-WT (f, upper row) mice.
Closed arrows indicate cells positive for BDNF (red) and parvalbumin
(green). Open arrows indicate cells expressing only BDNF (red). The
specificity of the BDNF antibody is shown by the lack of BDNF
immunostaining in BDNFPax2-KO and BDNFTrkC-KO mice (c, f, lower
rows). Scale bars=10 μm
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Fig. 3 Hearing function of BDNFPax2-KO and BDNFTrkC-KO mice
before and after acoustic trauma. Auditory thresholds of BDNFPax2-KO
(a, upper panel) and BDNFTrkC-KO (a, lower panel) mice analyzed by
click (a) and tone-burst-evoked ABR (b) before (KOc) and after acoustic
trauma (KOat). Compared to WT mice (WTc, WTat), BDNFPax2-KO are
less vulnerable [25]. BDNFTrkC-KO mice exhibited normal hearing
thresholds (a, lower panel, WTc, ears/mice: n=22/11; KOc, n=20/10;
p>0.999, two-way ANOVA) and show no significant difference to WT
mice after acoustic trauma (WTat, ears/mice: n=8/8; KOat, n=7/7; p=
0.543, two-way ANOVA). Error bars, SD. c DPOAE thresholds in
BDNFTrkC-WT and BDNFTrkC-KO mice were similar (WT, ears/mice:
n=19/10; KOn=20/10; p=0.482, two-way ANOVA). Error bars, SD. d
IHC ribbon counts of midbasal cochlear turns in BDNFTrkC-WT and
BDNFTrkC-KO mice before (WTc, KOc) and after noise exposure
(WTat, KOat). The ribbon number of BDNFTrkC-KO mice was not
significantly different from that of BDNFTrkC-WT animals. Error bars,
SEM, n.s. p>0.05; WTc, sections/mice: n=5/2; WTat, n=6/3; KOc, n=
11/4; KOat, n=7/2. e, f Comparison of click-evoked ABR wave
amplitudes in BDNFPax2-WT and BDNFPax2-KO mice (e) and
BDNFTrkC-WT (WTc, WTat) and BDNFTrkC-KO (KOc, KOat) mice (f)
before (WTc, KOc) and after noise exposure (WTat, KOat). In
BDNFPax2-KO, suprathreshold amplitudes of wave I (auditory nerve)
and wave IV (IC) are less reduced after noise exposure than in
BDNFPax2-WT mice (compare black and red arrows in e for different
reductions in WTand KO, respectively). In BDNFTrkC-KO, the reduction
was not different from the reduction in BDNFTrkC-WT mice (compare
black and red arrows in f for similar reduction in WT and KO,
respectively). Two-way ANOVA with Bonferroni’s post hoc test (e)
wave I, n.s. p=0.254; wave IV, n.s. p=0.893; WTat, ears/mice: n=8/4;
KOat, n=7/4; fwave I, *p=0.04; wave IV, *p=0.02;WTat, mice/ears: n=
8/16; KOat, n=8/16; error bars, SEM. g–j Suprathreshold ABR
amplitude at the level of the auditory nerve (wave I) and IC (wave IV).
Analysis was performed before and after acoustic trauma in BDNFPax2-
WT (WTc, n=16/8 ears/mice; WTat, n=16/8 ears/mice) and BDNFPax2-
KO mice (KOc, n=16/8 ears/mice; KOat, n=16/8 ears/mice) (g, h)
compared to BDNFTrkC-WT (WTc, n=17/8 ears/mice; WTat, n=8/
4 ears/mice) and BDNFTrkC-KO mice (KOc, n=15/8 ears/mice; KOat,
n=7/4 ears/mice) (i, j). Note the near-complete convergence of growth
functions of ABR wave I (g, n.s. p=0.275; i, **p=0.008) and IV (h, n.s.
p=0.420; j, ***p<0.001) before and after AT in BDNFPax2-KO but not in
BDNFTrkC-KO mice. Two-way ANOVAwith Bonferroni’s post hoc test,
error bars, SEM
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CF, WTc: Mdn=19.18; KOc: Mdn=35.14, **p<0.01; high
CF, WTc: Mdn=30.28; KOc: Mdn=39.38, ***p<0.001)
and tended to be smaller after AT in BDNFPax2-KO mice in
these CF ranges (Fig. 5b). Low CF thresholds in BDNFPax2-
KO mice were not significantly different from WT, even
though no units with thresholds below ∼30 dB SPL could be
found (Fig. 5b, WTc: Mdn=24.34; KOc: Mdn=40.39, n.s.
p>0.05). Thresholds of individual IC neurons as a function
of CF are presented in scatter plots for BDNFPax2-WT and
BDNFPax2-KO animals (Fig. 5c). Finally, the parameters of
the RIFs such as dynamic range (WTc 52.37±11; KOc 43.23
±11, ****p<0.0001) and slope (WTc 0.01424±0.006; KOc
0.01919±0.007, ****p<0.0001), but not maximum response
magnitude (WTc 20.52±12.48; KOc 21.83±15.56, n.s.
p>0.05) of IC neurons, were significantly reduced in
BDNFPax2-KO mice and significantly less pronounced after
AT in BDNFPax2-KO than in BDNFPax2-WTmice (Fig. 5d, e).
These findings reveal that after the onset of hearing, BDNF
in lower brain parts improves sound-evoked ABR amplitudes
generated at the level of the IC (ABR wave IVamplitudes) as
well as the threshold to which IC neurons can respond to
sound intensities above 10 kHz. This sensitivity to sound
can be lost after auditory nerve injury in the mature system
only when it has been established before with the onset of
hearing.
Deletion of BDNF in BDNFPax2-KO Mice Alters Latency
and Tuning Characteristic of IC Neurons
CF detection thresholds have been hypothesized to be influ-
enced by onset stimuli [53]. Differences in onset stimuli should
be reflected by differences in mFSL, which can be evaluated
from poststimulus time histograms. mFSLs for 80 dB SPL
stimuli were similar in BDNFPax2-WT and BDNFPax2-KO an-
imals for the low- and middle-frequency bands (Fig. 6a; low
CF, 4–9 kHz, WTc: Mdn=7.28; KOc: Mdn=7.4, n.s. p>0.05;
middle CF, 10–15 kHz, WTc: Mdn=6.8; KOc: Mdn=6.9, n.s.
p>0.05), but were significantly longer for neurons with high
CF (16–30 kHz) (Fig. 6a; WTc: Mdn=6.8; KOc: Mdn=7.5,
****p<0.0001). After AT, mFSLs were less enlarged in
BDNFPax2-KO mice for neurons with both middle and high
Fig. 4 Immunohistochemistry of outer hairs cells (OHC, arrows) in
BDNFPax2-WT (n=4, left panels) and BDNFPax2-KO (n=4, right
panels) mice. OHCs are stained for the voltage-gated potassium
channel KCNQ4 (a), parvalbumin (b), the small conductance calcium-
activated potassium channel SK2 (c), the large-conductance calcium-
activated potassium channel BK (d), and CtBP2, a marker of ribbon
synapses (e). f In contrast to OHCs, IHCs show reduced number of
CtBP2-stained ribbons in BDNFPax2-KO mice. Arrowheads indicate
antibody staining. g Quantification of ribbons stained with anti-CtBP2.
No differences are observed in any row of the OHCs or in the mean
ribbon number of OHCs, although a significantly reduced ribbon
number can be seen in IHCs. Two-tailed unpaired Student’s t test with
α=5 (*p<0.05). Scale bars=5 μm
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CF (Fig. 6a, middle CF, WTat: Mdn=10.7; KOat: Mdn=8.5,
***p<0.001; high CF, WTat: Mdn=9.8; KOat: Mdn=7.9,
****p<0.0001). This indicates that after the onset of hearing,
BDNF improves the short latency responses of IC neurons to
sound. Only when these responses have been developed, such
as in BDNFPax2-WT mice, this faster response behavior can be
lost after traumatizing noise in the mature system.
The quality factor Q10 of sound responses of IC neu-
rons, which is reciprocally related to the excitatory area
bandwidth 10 dB above threshold (the higher the Q10,
the sharper the tuning), may help to identify the type of
neuron which responds to BDNF in the IC. Q10 did not
significantly differ between BDNFPax2-WTc and
BDNFPax2-KOc mice over all CF ranges (Fig. 6b).
However, after AT, Q10 in neurons with middle and
high CF in BDNFPax2-WTat mice was significantly
more reduced than in BDNFPax2-KOat animals
(Fig. 6b, n.s. p>0.05, **p<0.01, ****p<0.0001). Dif-
ferences in peak Q10 values in scatter plots categorized
for frequency bands in control and KO animals
(Fig. 6c, d) prompted us to investigate individual Q10
values. Interestingly, in CF regions >10 kHz, the num-
ber of IC neurons with Q10 values >4 was significantly
lower in sham-exposed BDNFPax2-KO than in sham-
exposed BDNFPax2-WT animals (Fig. 6e, *p<0.05,
**p<0.01). This indicates that after the onset of hear-
ing, BDNF in lower brain parts sharpens a very narrow
tuning characteristic of IC neurons. Only when this
Fig. 5 Response thresholds of IC neurons to broadband noise (BBN) and
tone stimulation for control or sound-exposed BDNFPax2wild-type (WTc,
WTat) and BDNFPax2 knockout (KOc, KOat) animals. a Averaged
thresholds of responses to BBN stimulation. b Box and whisker plot for
thresholds of tone-evoked responses for neurons of individual CF
frequency ranges (4–9, 10–15, 16–30 kHz). c Scatter plots of pure tone
thresholds as a function of neuronal CF, shown separately for BDNFPax2-
WT (WTc, n=4;WTat, n=5) and BDNFPax2-KO (KOc, n=4;KOat, n=5)
animals. d, e Parameters of the rate-intensity function (RIF) of responses
to BBN stimulation for control or sound-exposed BDNFPax2-WT (WTc,
WTat) and BDNFPax2-KO (KOc, KOat) animals. d Typical examples of
RIFs for all groups of animals. e Average dynamic range, relative slope,
and maximum response for all groups of mice. One-way ANOVA with
Bonferroni’s post hoc test and Kruskal-Wallis test with Dunn’s multiple
comparison test, n.s. p>0.05, *p<0.05, **p<0.01, ***p<0.001,
****p<0.0001. Data are presented as mean±SD or median with
interquartile range and extremes. The numbers in the graphs indicate
the numbers of neurons
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sharpening has developed (e.g., in BDNFPax2-WT) it
can be lost after traumatizing noise in the mature
system.
Deletion of BDNF in BDNFPax2-KO Mice Affects
the Inhibitory Strength of IC Neurons
To investigate the difference in tuning characteristics of IC
neurons in more detail, inhibitory, excitatory, and
noninhibitory (Fig. 7) response characteristics of IC neu-
rons of sham-exposed and noise-exposed BDNFPax2-WT
and BDNFPax2-KO mice were investigated using two-
tone inhibition. In both groups of sham-exposed mice al-
most 80 % of neurons displayed low-frequency and/or
high-frequency lateral inhibition. Likewise, after intense
noise exposure, there was a likewise drop in the number
of neurons displaying lateral inhibition in both groups of
animals (data not shown).
Next, the strength of firing rate suppression by lateral
inhibition was calculated as a percentage of rate suppres-
sion separately for low- and high-frequency sideband inhi-
bition for neurons with a CF <10 kHz and CF >10 kHz.
Low CF neurons did not exhibit altered low- or high-
frequency sideband inhibitory strengths in the absence of
BDNF or after AT (Fig. 7b). Likewise, in the neurons with
a CF of 11–30 kHz, the low-frequency sideband was sim-
ilar in BDNFPax2-WT and BDNFPax2-KO animals
(Fig. 7b). However, high-frequency sideband inhibition
strength was significantly reduced in sham-exposed
BDNFPax2-KO mice (Fig. 7b, *p<0.05). Moreover, the
pronounced drop in the strength of high-frequency inhibi-
tion after AT observed in BDNFPax2-WT mice was not
f o u n d i n BDNF P a x 2 - KO a n i m a l s ( F i g . 7 b ,
****p<0.0001). This indicates that after the onset of hear-
ing, BDNF in lower brain parts increases the inhibitory
strength of IC neuron that can be dropped after AT only
when it has been increased before.
The stimulus-induced spike rates of IC neurons with
middle and high CF in excitatory and noninhibitory re-
gions were significantly elevated after AT in BDNFPax2-
WT in comparison to BDNFPax2-KO mice (Fig. 7c). This
is likely due to the drop in BDNF-driven inhibitory
strength after AT in BDNFPax2-WT but not in BDNFPax2-
KO mice (Fig. 7b). Importantly, these higher spike rates in
BDNFPax2-WTat animals occur without a corresponding
increase in sound-evoked spike output as revealed through
a smaller ratio between spikes in excitatory and
noninhibitory areas in BDNFPax2-WTat but not BDNFPax2-
KOat mice (Fig. 7d). When the spontaneous firing rates of
IC neurons from poststimulus histograms for BBN were
Fig. 6 Minimum first spike latency (mFSL) and quality factor (Q10) of
IC neurons. a mFSL of responses to 80 dB SPL BBN bursts for control
and sound-exposed BDNFPax2-WT (WTc, n=4; WTat, n=5) and
BDNFPax2-KO (KOc, n=4; KOat, n=5) animals. Box and whisker plot
for mFSL for neurons of individual CF frequency ranges (4–9, 10–15,
16–30 kHz). Kruskal-Wallis test with Dunn’s post hoc test: n.s. p>0.05,
*p<0.05, ***p<0.001, ****p<0.0001. Data are presented as medians
with interquartile ranges and extremes. b–e Q10 of IC neuron responses
to pure tone stimulation for control and sound-exposed BDNFPax2-WT
(WTc, n=4; WTat, n=5) and BDNFPax2-KO (KOc, n=4; KOat, n=5)
animals. b Box and whisker plot for Q10 for neurons of individual CF
frequency ranges (4–9, 10–15, 16–30 kHz). c Scatter plots illustrating the
Q10 as a function of neuronal CF, shown separately for BDNF
Pax2-WT
and BDNFPax2-KO animals. d, e Scatter plots forQ10 with y scale 0–8 (d)
and scale 4–8 (e) for the neurons of individual frequency ranges (4–9, 10–
15, 16–30 kHz). Note that IC neurons >10 kHz with Q10 >5 are absent in
BDNFPax2-KO mice (e). Kruskal-Wallis test with Dunn’s multiple
comparison test: n.s. p>0.05, **p<0.01, ****p<0.0001. Data are
presented as medians with interquartile ranges and extremes. The
numbers in the graphs indicate the numbers of neurons
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Fig. 7 Inhibition characteristics in control or sound-exposed BDNFPax2-
WT (WTc, n=4;WTat, n=5) and BDNFPax2-KO (KOc, n=4;KOat, n=5)
animals. a Schematic of response map to two-tone stimulation showing
excitatory, inhibitory, and noninhibitory areas. b Comparison of low- and
high-frequency sideband inhibition strength in middle and high CF (11–
30 kHz) IC neurons with inhibitory strength of 1 % and higher. One-way
ANOVAwith Bonferroni’s post hoc test. c Spike rates of IC neurons with
middle and high CF in response to two-tone stimulation, determined
20 dB above threshold in the excitatory area and noninhibitory area.
Numbers in the graph indicate number of neurons. d Ratio of spike
rates in the excitatory field 20 dB above threshold to spike rates in the
noninhibitory area. The numbers of neurons are given above the
corresponding boxes. Kruskal-Wallis test with Dunn’s multiple
comparison test: n.s. p>0.05, *p<0.05, ***p<0.001, ****p<0.0001.
Data are presented as mean±SD or median with interquartile range and
extremes. e Distribution of IC neurons according to their spontaneous
firing rate (spikes/s) for control and sound-exposed BDNFPax2-WT
(WTc, n=4; WTat, n=5) and BDNFPax2-KO (KOc, n=4; KOat, n=5)
animals. f Spontaneous firing rates for neurons with CF in the high-
frequency band (10–30 kHz) were significantly higher in BDNFPax2-
WTat than in BDNFPax2-WTc but were similar in BDNFPax2-KOat and
BDNFPax2-KOc. Kruskal-Wallis test with Dunn’s post hoc test
demonstrated significant differences between WTc and WTat
(**p<0.01) and WTat and KOat (***p<0.001) groups of animals. Data
are presented as mean±SD or median with interquartile range and
extremes. The numbers in the graphs indicate the numbers of neurons
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assessed after AT in BDNFPax2-WT mice (Fig. 7e), there
was a significant drop in the proportion of neurons with a
spontaneous firing rate close to 0 (0–3 spikes/s) (32 % for
WT to 61 % for KO, ***p<0.001) and a shift of the dis-
tribution toward neurons with a higher spontaneous activ-
ity compared to BDNFPax2-KOat animals (WT: Mdn=3.8
to Mdn=7.13, **p<0.01; KO: Mdn=4.13 to Mdn=2.8,
n.s. p>0.5). These results underscore the loss of suppres-
sion of a BDNF-dependent firing rate. When spontaneous
firing rates for low, middle, and high CF regions were
analyzed separately, a significantly enhanced spontaneous
firing rate for a CF >10 kHz after AT in BDNFPax2-WT but
not in BDNFPax2-KO mice was observed (Fig. 7f). This
finding strengthens the conclusion that BDNF may im-
prove signal-to-noise ratio by increasing the inhibitory
strength of neurons under basal conditions.
Deletion of BDNF in BDNFPax2-KO but not
BDNFTrkC-KO Mice Reduces the Density
of PV-Immunopositive Puncta in IC and AC Projecting
Neurons
In many projection neurons, changes in inhibitory conduc-
tances are assumed to require specialized GABA (γ-
aminobutyric acid)A receptors. Particularly, the differentiation
of PV basket cells, a subpopulation of GABAergic neurons
that regulate a critical period of plasticity in the cortex which
depends on BDNF (for a review, see [54]), may play a role
during the alteration of inhibitory strength in BDNFPax2-KOs.
Likewise, elevated auditory startle amplitude and latencies in
PV−/− mice suggested a specific role of PV basket cells for
inhibitory circuits in auditory processing [55]. To investigate a
role of PV for the observed changes in inhibitory strength in
BDNFPax2-KO mice, we used antibodies for PV [56, 57] and
antibodies for the 67-kDa isoform of GABAergic interneu-
rons. We found that the intensity and number of PV-
immunopositive puncta, but not the number of PV-
immunopositive somata or GAD67-immunopositive puncta
(not shown), are decreased in the IC and AC of BDNFPax2-
KO (Fig. 8a, c) but not in BDNFTrkC-KO mice (Fig. 8b, d).
Reduced levels of PV expression could also be confirmed by
Western blots (Fig. 8a, b, inset). Quantification of the intensity
of labeling revealed a significantly reduced number and inten-
sity of PV-positive puncta (Fig. 8e, 10–20 slices of 3–6 inde-
pendent experiments of n=3 animals) in BDNFPax2-KO mice.
Also in the hippocampus, PV levels were reduced in
BDNFPax2-KO but not in BDNFTrkC-KOmice, as exemplarily
shown by Western blots (Fig. 8h). Interestingly, the reduction
of PV levels in BDNFPax2-KO mice was associated with ele-
vated levels of the immediate early gene Arc (activity-regulat-
ed cytoskeletal protein), as exemplarily shown for the hippo-
campus (Fig. 8h, n=3–5). Arc is mobilized in glutamatergic
neurons following, e.g., long-term potentiating (LTP)-like
activity [58, 59]. As BDNFPax2-KO mice do not lack BDNF
in the AC and hippocampus (Fig. 1c, e), future studies are
required to investigate a potential developmental downregu-
lation of Arc levels mediated by BDNF-dependent increases
in inhibitory strength following onset of sensory function.
In conclusion and as outlined in Fig. 9, the data in the
present study suggest that BDNF in the lower parts of the
auditory system or within the cochlea (and not in the upper
central auditory system) (Fig. 9 [1]) alters the afferent driving
force for sound processing toward a wider dynamic range to
which IC neurons can respond to sound intensities (Fig. 9 [2]).
This is possibly mediated by generation and maintenance of
increased inhibitory PV contacts with the auditory brain net-
work that leads to enhanced spike probability in response to
sensory stimulation. As shown for IC neurons, the BDNF-
modified afferent driving force shortens response latency
(Fig. 9 [3]) and lowers the CF detection threshold in IC neu-
rons (Fig. 9 [4]) through the generation of a high-frequency
inhibitory sideband (Fig. 9 [5]) in, e.g., very narrowly tuned
IC neurons (Fig. 9 [6]). This suggests that the auditory driving
force which depends on BDNF in the lower parts of the audi-
tory CNS or within the cochlea may improve fidelity through
enhancing the inhibitory strength within the auditory-specific
network. When this driving force is lost after auditory nerve
injury, such as following acoustic trauma, as shown here for
traumatized BDNFPax2-WTanimals, the auditory-specific net-
work may lose its normal signal-to-noise ratio within the af-
fected frequency range.
Discussion
The present study supports the hypothesis that the matura-
tion of auditory nerve activity depends on BDNF in the
lower parts of the auditory CNS or within the cochlea
and is required to improve the fidelity of sound-induced
responses after the onset of hearing. Improved auditory
fidelity under control of this BDNF-dependent process is
most likely achieved through enhancement of basal inhib-
itory circuits in the ascending auditory pathway. In the
mature auditory organ, this BDNF-dependent driving force
can be lost during, e.g., cochlear injury, leading to an ele-
vated spontaneous firing rate, independently of a corre-
sponding increase in sensory-evoked spikes.
Peripheral but not Central BDNF Drives Changes
in Sound Processing
We show here that BDNF present in the lower parts of the
auditory CNS or the peripheral end organ improves the thresh-
old for sound and the dynamic range of sound responses. In
both BDNFPax2-KO [25] and BDNFTrkC-KO animals (present
study), BDNF is deleted in SGNs and in the IC, suggesting
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that alterations of BDNF activities in these compartments are
unlikely to be responsible for the differences between sound-
induced ABR wave I and IV responses in these mice. As
BDNFPax2-KO mice do not have a BDNF deletion in neither
the AC, VCN, or olivary complex [present study] [25], de-
scending central feedback loops are also unlikely to be in-
volved. The observed hearing phenotype in BDNFPax2-KO
mice may therefore be linked to a Pax2-driven BDNF deletion
in the lower parts of the auditory CNS or the cochlea. In the
cochlea, BDNF is expressed postnatally in phalangeal, SGN,
or satellite cells [22, 25, 50, 60]. Given that (i) BDNF deletion
in phalangeal cells does not affect hearing thresholds [23], (ii)
BDNF deletion in SGNs and in a minor number of supporting
cells as observed in BDNFTrkC-KO mice does not lead to an
auditory phenotype, and (iii) BDNF expression in inhibitory
interneurons has been excluded [52, 61], the loss of BDNF
expression in glial cells may be considered as being responsi-
ble for the observed phenotype in BDNFPax2-KO animals.
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Peripheral BDNF Improves Amplitudes of Spreading
Sound-Induced Activity
In our previous study, reduced exocytosis in otherwise
mature IHCs in high-frequency cochlear turns of 2–3-
week-old BDNFPax2-KO mice [25] pointed out a critical
role of BDNF for pre- and postsynaptic maturation of
IHCs. The alterations in ABR waves I and IV found in
the present study in BDNFPax2-KO but not BDNFTrkC-KO
mice indicate that BDNF activities that are carried out
independently of higher auditory brain regions improve
sound sensitivity at least up to the level of the IC. We
assume that in BDNFPax2-KO mice the decrease of ABR
wave I and IV amplitude observed before AT and its re-
duced decline after AT occurs independently of the elec-
tromechanical properties of OHCs for the following rea-
sons: (i) within the range of the stimulus levels in which
ABR functions were quantified, no difference in DPOAEs,
used as a measurement for mechanical properties of
OHCs, was found; (ii) changes of suprathreshold re-
sponses after AT are seen in BDNFPax2-KO mice, but no
differences are observed in DPOAE amplitudes after AT;
and (iii) BDNF is not deleted in the olivocochlear
brainstem nuclei that are projection fields of efferent fibers
toward OHCs [25]. BDNF is therefore more likely to
improve ABR amplitudes through its influence on IHC
exocytosis and/or auditory fiber sensitivity for low sound
thresholds. In this context, it is important to consider that
low-threshold fiber characteristics develop only after hear-
ing onset [62, 63]. Also in the visual system, a role of
retinal BDNF for improved retinal and visual acuity has
been suggested [64]. Accordingly, an antisense-based inhi-
bition of BDNF in the retina prevented an improvement of
retinal stripe segregation induced by environmental enrich-
ment as well as cortical acuity, even prior to eye opening
[16, 17, 64]. To date, conditional deletion of retinal BDNF
has not been performed, and it is therefore elusive if it
improves the baseline of visual sensitivity independently
of environmental enrichment, similar to the present
findings.
BDNF Drives Increased Inhibitory Strength
Along the Auditory Pathway
The current findings suggest that BDNF-dependent effects on
auditory nerve activity are responsible not only for improving
the ABR amplitude size of high-frequency sound responses
spreading along the ascending pathway, but also for
expanding the range of CF thresholds in these high-
frequency CF regions. The affected CF regions >10 kHz span
areas (15–20 kHz) where murine behavioral auditory thresh-
olds are at their lowest level [65].We thus have to consider the
improved CF thresholds, short latencies, and the increased
strength of inhibitory sidebands of sharply tuned IC neurons
in BDNFPax2-WT versus BDNFPax2-KO animals in the con-
text of an enhanced auditory fidelity in behaviorally relevant
frequency regions. The IC neurons that show altered tuning
characteristics depending on the presence of BDNF are rem-
iniscent of type II [65] and type I [66] class IC neurons. Both
IC cell types predominate in high-frequency regions and are
characterized by their short latency, narrow and sharp tuning,
low-frequency border with a shallow slope, and high-
frequency border with a steep slope [65, 66]. It thus may be
considered that these neurons are shaped under the control of
BDNF activities at hearing onset.
In BDNFPax2-KO animals, the proportion of neurons
with an elevated spontaneous firing rate is slightly, how-
ever not yet significantly, increased. After AT, however, a
significant drop in neurons with a lower spontaneous firing
rate and an increase in neurons with a higher spontaneous
firing rate in BDNFPax2-WT mice compared to BDNFPax2-
KO animals support a loss of the BDNF-dependent rate of
firing suppression after auditory nerve injury. Reminiscent
to this finding, a reduced rate of firing suppression that
leads to an increase of the spontaneous firing rate without
a stimulus-evoked spike output was described after a
blockade of tonic inhibition in granule cells of the cerebel-
lar cortex [67]. It is currently assumed that tonic inhibition
suppresses spontaneous activity through reduction of the
neuronal input resistance and membrane time constants,
Fig. 8 Immunohistochemistry of the inferior colliculus and auditory
co r t ex o f BDNFPa x 2 -KO and BDNFTr kC -KO mice . a–d
Immunohistochemistry of the IC and AC of BDNFPax2-KO (a, c) and
BDNFTrkC-KO mice (b, d) immunolabeled with anti-parvalbumin (red)
and anti-GAD67 (green). A reduction of PV- and GAD67-
immunoreactive puncta in both IC (a) and AC (c) in BDNFPax2-KO
mice compared to BDNFPax2-WT mice is observed. Arrows point to
PV-immunoreactive puncta. No changes in PV and GAD67 expression
are observed in the IC (b) and AC (d) of BDNFTrkC-KO mice compared
to BDNFTrkC-WT mice. Arrows point to PV-immunoreactive puncta.
Reduced PV levels in BDNFPax2-KO but not BDNFTrkC-KO mice in
the IC are confirmed by Western blot (a, b insets). e, f Quantification of
PV-immunoreactive puncta in the IC (e) of BDNFPax2-WT, BDNFPax2-
KO, BDNFTrkC-WT, and BDNFTrkC-KO mice (10–20 slices of 3–6
independent experiments of n=3 animals) and in the AC (f) of
BDNFPax2-WT, BDNFPax2-KO, BDNFTrkC-WT, and BDNFTrkC-KO
mice (10–20 slices of 3–6 independent experiments of n=3 animals).
Two-way ANOVA with Bonferroni’s post hoc test (**p<0.01, ***p<
0.001). Data are presented as mean±SD. g Immunohistochemistry of
AC sections of BDNFPax2-WT (upper image) and BDNFPax2-KO
(lower image) mice immunolabeled with anti-Arc (red) and anti-
parvalbumin (green) antibodies. In BDNFPax2-KO mice, Arc (red)
expression is reduced. Closed arrows point to PV-positive cells. Open
arrows indicate PV-immunoreactive puncta surrounding Arc-positive
neurons. Scale bars=10 μm. h Parvalbumin (PV) and Arc levels in the
hippocampus of BDNFPax2-WTand BDNFPax2-KOmice and BDNFTrkC-
WT and BDNFTrkC-KO mice, respectively, detected by Western blots
(exemplarily for n=3–5 mice). Note that the reduction of PV is
associated to an increase of Arc in BDNFPax2-KO but not BDNFTrkC-
KO mice
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thereby improving stimulus discrimination above noise
[68]. The ability of tonic inhibition to change conductances
in many neurons is assumed to require perisynaptic and
extrasynaptic δ subunit-containing GABAA receptors,
which are likely to be activated through fast-spiking, PV-
expressing, and soma-inhibiting interneurons [69]. PV-
expressing interneurons play a crucial role for hippocam-
pal microcircuit formation and plasticity changes [70]. The
significant loss of density of PV-immunopositive puncta in
the IC and AC and the first evidence for declined PV levels
associated with elevated Arc levels in the hippocampus of
BDNFPax2-KO but not in BDNFTrkC-KO mice may suggest
that a BDNF-modified driving force for auditory process-
ing improves the baseline for mature circuit formation and
plasticity changes along the entire ascending auditory net-
work. This finding, moreover, suggests that the altered
brain network activity shaped under the influence of
BDNF in the lower parts of the auditory CNS or within
the cochlea is a prerequisite for cortical maturation pro-
cesses that occur with sensory experience [71–73]. The
influence of dendritogenesis of PV-containing interneurons
in the olfactory bulb [12], the auditory [8], visual [17, 74],
and somatosensory cortex [11] on improved spectral and
temporal cortical response properties [71–73] should be
reconsidered in the context of these findings.
Peripheral BDNF Improves Sound Fidelity but Carries
the Risk to Enhance Central Noise Following Its Loss
After Injury
We observed here that suprathreshold ABR wave IV and CF
threshold in IC neurons after AT were persistently more ele-
vated in BDNFPax2-WT than in BDNFPax2-KO mice. This
may be explained by a loss of auditory fiber characteristics
that depend on BDNF and that are essential to maintain tonic
inhibitory strength in the ascending pathways. As a result,
spontaneous firing rates may be elevated within the affected
frequency range without leading to sound-induced output as
shown here in BDNFPax2-WT but not in BDNFPax2-KO mice.
A persistent reduction of suprathreshold amplitudes at the
level of the IC has also been observed in traumatized rats with
behaviorally tested tinnitus [38, 60] indicating that lost audi-
tory nerve fiber activities that are typically maintained by
BDNF in the lower parts of the auditory CNS or within the
cochlea may be causally related to “phantom” noise. Previous
observations that describe elevated intensity discrimination
thresholds in tinnitus subjects with normal audiograms [75]
may be re-examined in the context of a loss of signal-to-noise
ratio in those frequency bands in which the BDNF-dependent
driving force is lost. When the BDNF-dependent driving force
is lost, the baseline levels required to allow the development
Fig. 9 Schematic summary of the results that illustrates our hypothesis.
An auditory driving force which is modified with hearing onset and
depends on BDNF in the lower parts of the auditory system or within
the cochlea [1] widens the dynamic range above which spike rates can be
detected [2]. This is achieved upon shortening of the response latency [3],
leading to lowering of the detection threshold [4] through generation of a
high-frequency inhibitory sideband [5] in, e.g., very narrowly tuned IC
neurons [6]. Through these events, the probability to detect a spike above
the noise floor may be improved. This BDNF activity on auditory fibers
in high-frequency cochlear turns can be lost after acoustic trauma. In this
case, spontaneous spike rates in central auditory pathways are elevated
(hyperactivity). As a consequence, due to loss of basal inhibitory strength
within the ascending circuit of affected frequency regions, the capacity to
adapt to sensory deprivation might be reduced. HF high frequency, IC
inferior colliculus, IHC inner hair cell, LF low frequency
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of a normal adaptation of central brain responses after cochle-
ar injury may be lost. In view of the current findings, a BDNF-
dependent auditory driving force may thus be the prerequisite
for adaptive responses and central gain [76] after sensory dep-
rivation [74, 77, 78]. Central maladaptive hyperactivities in
various brain disorders including pain, Alzheimer, or epilepsy
[79–81] and their enigmatic relationship to BDNF may be
revisited in the context of the current findings [20, 21, 80].
For these disorders, a critical loss of the BDNF-dependent
driving force should be taken into account.
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